UBS: Raises ASMPT (00522) target price to HK$135 Potential divestment of SMT business is positive
ASM Pacific Technology (ASMPT) announced that it is currently evaluating options for its Surface Mount Technology (SMT) business, which may involve selling, partnership, spin-off, or IPO. UBS believes that this move is positive.
UBS released a research report stating that due to the improvement in growth visibility of the Thermo-Compression Bonding (TCB) business, the earnings forecast for ASMPT (00522) for the current and next year have been raised by 3% and 4% respectively. The valuation basis has been extended to 2027, with a forecasted P/E ratio of 24 times, and the target price has been raised from HK$95 to HK$135, with a "Buy" rating.
ASMPT announced that it is evaluating options for its Surface Mount Technology (SMT) business, which may involve selling, partnering, spinning off, or listing. UBS believes that this move is positive as the company can focus on semiconductor and advanced packaging, streamlining operations and resource allocation. The SMT business traditionally has lower profit margins and technology barriers compared to the semiconductor industry, with different industry cycles. If ASMPT chooses to divest or spin off the SMT business, due to opportunities in advanced packaging, profit margin and earnings are expected to structurally increase, leading to potential revaluation. The bank currently trades at a P/E ratio of 18 times for the forecasted 2027, lower than international peers.
Related Articles

VENUS MEDTECH-B(02500): Cardiovalve Ltd. and MTH IP, L.P. filed a patent infringement lawsuit against Edwards for US Patent No. 385.

HK Stock Market Move | CMOC Group Limited (03993) fell nearly 4% in the morning, with the issuance of $1.2 billion convertible bonds completed. The dilution risk of the Hang Seng Index is limited.

GFSEC: Early-stage equipment manufacturers in the space photovoltaic industry are the first to benefit. It is recommended to pay attention to HJT/perovskite equipment suppliers and other links.
VENUS MEDTECH-B(02500): Cardiovalve Ltd. and MTH IP, L.P. filed a patent infringement lawsuit against Edwards for US Patent No. 385.

HK Stock Market Move | CMOC Group Limited (03993) fell nearly 4% in the morning, with the issuance of $1.2 billion convertible bonds completed. The dilution risk of the Hang Seng Index is limited.

GFSEC: Early-stage equipment manufacturers in the space photovoltaic industry are the first to benefit. It is recommended to pay attention to HJT/perovskite equipment suppliers and other links.

RECOMMEND

Moving Toward “7*24 Hour” Trading! NYSE Seeks Approval For “All‑Weather Blockchain Trading Platform”
21/01/2026

China Internet 2026: Under Pressure From ByteDance, Major Players Launch Full‑Scale Contest For AI Entry Points
21/01/2026

Hong Kong Equity Refinancing Opens Strong In 2026, Raising Over HKD 27 Billion
21/01/2026


